Institutional investors purchased a net $19.7 thousand shares of ATRI during the quarter ended September 2016. This may signal that the smart money is gaining interest in this company as the 57.33% of shares outstanding that institutional investors hold is actually below the Medical Specialties industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
VANGUARD INVESTMENTS AUSTRALIA L... Bought 162.00 shares of Atrion Corp